Home > Formulary : Paediatric > Paediatric Chapters > 5. Infections >
BNSSG Paediatric Joint Formulary
5.7 Treatment of COVID-19
Last edited: 25-06-2024
5.7.1 COVID-19
Neutralising monoclonal antibodies (nMABs) in the treatment of COVID-19
Sotrovimab (Xevudy®) (TLS Red)
- For patients over the age of 12 as per:
- NICE TA878 Casirivimab plus imdevimab, nirmatrelvir plus ritonavir, sotrovimab and tocilizumab for treating COVID-19
- For use as per NHS Clinical Commissioning Policy. See CAS Alert documents here
Antivirals in the treatment of COVID-19
Remdesivir (TLS Red)
- NICE TA971 Remdesivir for treating COVID-19
- For use as per NHS Clinical Commissioning Policy. See CAS Alert documents here